June 17, 2019

Long-Awaited Plan for Potential National Opioid Settlement Revealed

Long-Awaited Plan for Potential National Opioid Settlement Revealed

In response to the devastating national opioid crisis, attorneys for local governments filed a possible plan that could lead pharmaceutical companies and U.S. communities to a global settlement of opioid lawsuits. The plan, filed in the Ohio federal court June 14, still needs to be approved by the court, but it could aid tens of thousands of communities in recovering from the opioid addiction crisis.

Thousands of communities across the United States have filed lawsuits against pharmaceutical companies for aggressively marketing and selling prescription opioids without revealing the addictive nature of the drugs. According to the Centers for Disease Control and Prevention, over 200,000 Americans have been killed due to opioid overdoses, and opioid addiction treatment requires substantial time and funding to adequately address.

The final payouts of the proposed plan could direct billions of dollars to communities struggling with the opioid crisis, potentially rivaling the tobacco settlements of the 1990s. The co-lead counsel for attorneys filing this framework say this plan is a step towards addressing the national epidemic, and it may allow for defendant companies to reach some sort of closure to the massive numbers of lawsuits they face. While the proposal is preliminary, it could result in defendant companies reaching multiple settlements, where all the separate companies or groups of companies contribute to a national fund created to help the opioid epidemic.

The constant battle between local governments and defendant pharmaceutical companies in opioid-related lawsuits has resulted in massive company settlements. In March 2019, Purdue Pharma reached a $270 million settlement with the state of Oklahoma for its hand in the opioid crisis. But other companies, like Insys Therapeutics, have been driven to or are considering bankruptcy to handle the overwhelming wave of lawsuits. None of the defendant companies have approved the newly proposed settlement plan yet, but plan approval could restore stability to one of the nation’s largest industries.

The pressure to reach an agreement between local communities and pharmaceutical companies involved in the opioid debacle increases as more lawsuits flood into the spotlight. Companies currently being sued include Johnson & Johnson, Purdue Pharma, CVS, and Walmart, with nearly 2,000 lawsuits filed nationwide.

Under the proposed plan, almost every community in America would be consolidated into a single “negotiating class”. NPR reports that the negotiating class distinction would mean local leaders would get the right “to approve or disapprove any settlements reached with drug companies. The vote would be weighted by population.” If 75% of involved communities agree on proposed deals, they would be finalized, paid out, and the company’s liability would end. Additionally, a separate emergency fund would be created for communities seriously suffering from the opioid crisis. Co-counsel states that upwards of billions of dollars would be needed to significantly help ease the opioid epidemic, but that all hinges on defendant companies’ approvals of the plan.

Recent Posts

22 People Hospitalized from Vaping-Linked Breathing Issues, but Doctors Unsure of Why

Nearly two dozen people have been hospitalized in the Midwest with serious breathing difficulties linked to vaping. However, doctors can’t pinpoint the answer why. NBC News reports doctors are struggling to identify what the patients—mostly young adults—inhaled or used as a vaping device. Additionally, medical officers have not been able to identify where patients purchased […]

Read More
FDA Vaping Seizures Investigation Uncovers 127 Cases Over Last Decade

Federal investigators discovered far more reports of seizures linked to vaping e-cigarettes than originally anticipated. On August 7, the FDA issued a press release stating their scientific investigation uncovered 127 reports of seizures linked to vaping electronic cigarettes. This number far surpasses the original number of 35 reports since 2010. The FDA launched their investigation […]

Read More
Report of $8 Billion Roundup Settlement Dismissed by Bayer Mediator

The attorney in charge of mediating the Roundup weedkiller litigation in the United States rejected reports of Bayer AG paying $8 billion to settle all Roundup weedkiller claims in the US. “Such a statement is pure fiction,” Feinberg asserted in an email on Friday. “Compensation has not even been discussed in the global mediation discussions.” […]

Read More

Contact Us Today!

1. We're on Your Side

2. We're Available 24/7

3. No Fees Unless You Win
ATTORNEY ADVERTISEMENT: Not available in all states, Andrew Van Arsdale, supervising attorney is licensed only in California and Nevada, but associates with attorneys throughout the country, Principal office: 3667 Voltaire Street, San Diego, California 92106. 

Consult a doctor on all medical decisions. Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death. No representation is made that the quality of the legal services performed is greater than the quality of the legal services performed by other lawyers. AVA Law Group, Inc. not accepting cases in states where this advertising conflicts with laws or state rules. Legal representation is not offered or available in Tennessee. While AVA Law Group, Inc. maintains joint responsibility, most cases are referred to other attorneys for principal responsibility.
© Copyright 2019 
Privacy PolicyTerms of Use